Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir—potential influence of censored observation. Authors' reply-Reference-Cited by-同舟云学术

Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir—potential influence of censored observation. Authors' reply

Published:2023-12-12 Issue:1 Volume:59 Page:138-139
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Chen Chien‐Hung¹^ORCID,Peng Cheng‐Yuan²³^ORCID

Affiliation:

1. Division of Hepatogastroenterology, Department of Internal Medicine Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine Kaohsiung Taiwan

2. Center for Digestive Medicine, Department of Internal Medicine China Medical University Hospital Taichung Taiwan

3. School of Medicine, China Medical University Taichung Taiwan

Abstract

LINKED CONTENTThis article is linked to Chen et al papers. To view these articles, visit https://doi.org/10.1111/apt.17602 and https://doi.org/10.1111/apt.17767

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/apt.17788

Reference6 articles.

1. Letter: Estimating the incidence of HBsAg seroclearance after cessation of tenofovir and entecavir ‐ potential influence of censored observation

2. Higher rate of HBsAg loss after discontinuation of tenofovir than entecavir in patients with chronic hepatitis B

3. Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis B

4. Long-term incidence and predictors of hepatitis B surface antigen loss after discontinuing nucleoside analogues in noncirrhotic chronic hepatitis B patients

5. The Incidence of Hepatitis B Surface Antigen Loss Between Hepatitis B E Antigen-Negative Noncirrhotic Patients Who Discontinued or Continued Entecavir Therapy